CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 31 filers reported holding CHAMPIONS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,998 | +1.8% | 5,564 | -34.9% | 0.00% | 0.0% |
| Q1 2023 | $34,367 | -10.9% | 8,549 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $38,556 | -39.8% | 8,549 | 0.0% | 0.01% | -54.5% |
| Q3 2022 | $64,000 | -7.2% | 8,549 | 0.0% | 0.01% | -35.3% |
| Q2 2022 | $69,000 | -1.4% | 8,549 | 0.0% | 0.02% | +21.4% |
| Q1 2022 | $70,000 | -48.5% | 8,549 | -50.0% | 0.01% | 0.0% |
| Q4 2021 | $136,000 | +56.3% | 17,098 | +100.0% | 0.01% | -26.3% |
| Q3 2021 | $87,000 | -1.1% | 8,549 | 0.0% | 0.02% | +18.8% |
| Q2 2021 | $88,000 | -9.3% | 8,549 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $97,000 | +5.4% | 8,549 | 0.0% | 0.02% | -10.0% |
| Q4 2020 | $92,000 | -70.2% | 8,549 | -74.4% | 0.02% | -75.6% |
| Q3 2020 | $309,000 | -11.5% | 33,441 | -8.5% | 0.08% | -7.9% |
| Q2 2020 | $349,000 | +102.9% | 36,533 | +56.9% | 0.09% | +67.9% |
| Q1 2020 | $172,000 | – | 23,288 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Battery Partners IX, LLC | 1,953,549 | $7,111,000 | 7.42% |
| NEA Management Company, LLC | 1,562,500 | $5,688,000 | 0.25% |
| SHEPHERD KAPLAN KROCHUK, LLC | 21,564 | $78,000 | 0.05% |
| Perceptive Advisors | 366,973 | $1,335,000 | 0.04% |
| Granite Investment Partners, LLC | 139,698 | $509,000 | 0.03% |
| Sandy Spring Bank | 8,333 | $30,000 | 0.00% |
| Veritas Investment Management (UK) Ltd | 2,083 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,753 | $6,000 | 0.00% |
| VANGUARD GROUP INC | 152,722 | $553,000 | 0.00% |
| MORGAN STANLEY | 3,500 | $13,000 | 0.00% |